AAAAAA

   
Results: 1-17 |
Results: 17
Modulation of omega-3/omega-6 polyunsaturated ratios with dietary fish oils in men with prostate cancer
Authors: Aronson, AJ Glaspy, JA Reddy, ST Reese, D Heber, D Bagga, D
Citation: Aj. Aronson et al., Modulation of omega-3/omega-6 polyunsaturated ratios with dietary fish oils in men with prostate cancer, UROLOGY, 58(2), 2001, pp. 283-288
T cell responses to HLA-A0201-restricted peptides derived from human alpha fetoprotein
Authors: Butterfield, LH Meng, WS Koh, A Vollmer, CM Ribas, A Dissette, VB Faull, K Glaspy, JA McBride, WH Economou, JS
Citation: Lh. Butterfield et al., T cell responses to HLA-A0201-restricted peptides derived from human alpha fetoprotein, J IMMUNOL, 166(8), 2001, pp. 5300-5308
Organochlorine pesticide content of breast adipose tissue from women with breast cancer and control subjects
Authors: Bagga, D Anders, KH Wang, HJ Roberts, E Glaspy, JA
Citation: D. Bagga et al., Organochlorine pesticide content of breast adipose tissue from women with breast cancer and control subjects, J NAT CANC, 92(9), 2000, pp. 750-753
Generation of T-cell immunity to a murine melanoma using MART-1-engineereddendritic cells
Authors: Ribas, A Butterfield, LH Hu, B Dissette, VB Chen, AY Koh, A Amarnani, SAN Glaspy, JA McBride, WH Economou, JS
Citation: A. Ribas et al., Generation of T-cell immunity to a murine melanoma using MART-1-engineereddendritic cells, J IMMUNOTH, 23(1), 2000, pp. 59-66
Fine specificity analysis of an HLA-A2.1-restricted immunodominant T cell epitope derived from human alpha-fetoprotein
Authors: Meng, WS Butterfield, LH Ribas, A Heller, JB Dissette, VB Glaspy, JA McBride, WH Economou, JS
Citation: Ws. Meng et al., Fine specificity analysis of an HLA-A2.1-restricted immunodominant T cell epitope derived from human alpha-fetoprotein, MOL IMMUNOL, 37(16), 2000, pp. 943-950
Hematologic supportive care of the critically ill cancer patient
Authors: Glaspy, JA
Citation: Ja. Glaspy, Hematologic supportive care of the critically ill cancer patient, SEMIN ONCOL, 27(3), 2000, pp. 375-383
Immune deviation and Fas-mediated deletion limit antitumor activity after multiple dendritic cell vaccinations in mice
Authors: Ribas, A Butterfield, LH Hu, B Dissette, VB Meng, WS Koh, A Andrews, KJ Lee, M Amar, SN Glaspy, JA McBride, WH Economou, JS
Citation: A. Ribas et al., Immune deviation and Fas-mediated deletion limit antitumor activity after multiple dendritic cell vaccinations in mice, CANCER RES, 60(8), 2000, pp. 2218-2224
Adenovirus-interleukin-12-mediated tumor regression in a murine hepatocellular carcinoma model is not dependent on CD1-restricted natural killer T cells
Authors: Andrews, KJ Ribas, A Butterfield, LH Vollmer, CM Eilber, FC Dissette, VB Nelson, SD Shintaku, P Mekhoubad, S Nakayama, T Taniguchi, M Glaspy, JA McBride, WH Economou, JS
Citation: Kj. Andrews et al., Adenovirus-interleukin-12-mediated tumor regression in a murine hepatocellular carcinoma model is not dependent on CD1-restricted natural killer T cells, CANCER RES, 60(22), 2000, pp. 6457-6464
Ex vivo expanded unselected peripheral blood: progenitor cells reduce posttransplantation neutropenia, thrombocytopenia, and anemia in patients with breast cancer
Authors: Paquette, RL Dergham, ST Karpf, E Wang, HJ Slamon, DJ Souza, L Glaspy, JA
Citation: Rl. Paquette et al., Ex vivo expanded unselected peripheral blood: progenitor cells reduce posttransplantation neutropenia, thrombocytopenia, and anemia in patients with breast cancer, BLOOD, 96(7), 2000, pp. 2385-2390
Stem cell factor
Authors: Lacerna, L Sheridan, WP Basser, R Begley, CG Crawford, J Demetri, G Moskowitz, CH Tricot, G Weaver, A Glaspy, JA
Citation: L. Lacerna et al., Stem cell factor, HEMATOPOIETIC STEM CELL TRANSPLANTION, 2000, pp. 31-46
Characterization of antitumor immunization to a defined melanoma antigen using genetically engineered murine dendritic cells
Authors: Ribas, A Butterfield, LH McBride, WH Dissette, VB Koh, A Vollmer, CM Hu, B Chen, AY Glaspy, JA Economou, JS
Citation: A. Ribas et al., Characterization of antitumor immunization to a defined melanoma antigen using genetically engineered murine dendritic cells, CANC GENE T, 6(6), 1999, pp. 523-536
Economic considerations in the use of peripheral blood progenitor cells tosupport high-dose chemotherapy
Authors: Glaspy, JA
Citation: Ja. Glaspy, Economic considerations in the use of peripheral blood progenitor cells tosupport high-dose chemotherapy, BONE MAR TR, 23, 1999, pp. S21-S27
Antitumor protection using murine dendritic cells pulsed with acid-eluted peptides from in vivo grown tumors of different immunogenicities
Authors: Ribas, A Bui, LA Butterfield, LH Vollmer, CM Jilani, SM Dissette, VB Glaspy, JA McBride, WH Economou, JS
Citation: A. Ribas et al., Antitumor protection using murine dendritic cells pulsed with acid-eluted peptides from in vivo grown tumors of different immunogenicities, ANTICANC R, 19(2A), 1999, pp. 1165-1170
p53 selective and nonselective replication of an E1B-deleted adenovirus inhepatocellular carcinoma
Authors: Vollmer, CM Ribas, A Butterfield, LH Dissette, VB Andrews, KJ Eilber, FC Montejo, LD Chen, AY Hu, B Glaspy, JA McBride, WH Economou, JS
Citation: Cm. Vollmer et al., p53 selective and nonselective replication of an E1B-deleted adenovirus inhepatocellular carcinoma, CANCER RES, 59(17), 1999, pp. 4369-4374
alpha-fetoprotein-specific genetic immunotherapy for hepatocellular carcinoma
Authors: Vollmer, CM Eilber, FC Butterfield, LH Ribas, A Dissette, VB Koh, A Montejo, LD Lee, MC Andrews, KJ McBride, WH Glaspy, JA Economou, JS
Citation: Cm. Vollmer et al., alpha-fetoprotein-specific genetic immunotherapy for hepatocellular carcinoma, CANCER RES, 59(13), 1999, pp. 3064-3067
Generation of human T-cell responses to an HLA-A2.1-restricted peptide epitope derived from alpha-fetoprotein
Authors: Butterfield, LH Koh, A Meng, W Vollmer, CM Ribas, A Dissette, V Lee, E Glaspy, JA McBride, WH Economou, JS
Citation: Lh. Butterfield et al., Generation of human T-cell responses to an HLA-A2.1-restricted peptide epitope derived from alpha-fetoprotein, CANCER RES, 59(13), 1999, pp. 3134-3142
A randomized phase 3 study of peripheral blood progenitor cell mobilization with stem cell factor and filgrastim in high-risk breast cancer patients
Authors: Shpall, EJ Wheeler, CA Turner, SA Yanovich, S Brown, RA Pecora, AL Shea, TC Mangan, KF Williams, SF LeMaistre, CF Long, GD Jones, R Davis, MW Murphy-Filkins, R Parker, WRL Glaspy, JA
Citation: Ej. Shpall et al., A randomized phase 3 study of peripheral blood progenitor cell mobilization with stem cell factor and filgrastim in high-risk breast cancer patients, BLOOD, 93(8), 1999, pp. 2491-2501
Risultati: 1-17 |